Does anyone have any experience using either Ampure or the Qiaquick qiagen columns to clean up small amounts of DNA? I'm only starting with 100ng of DNA and want to lose as little as possible along the way. Which one gives the best DNA recovery? Many thanks in advance.
Unconfigured Ad
Collapse
X
-
-
I recently make a library (Illumina protocol) from 100ng of ChIPed DNA and I used Qiagen columns and measured the recovery after each step using Qubit. After step 1 (end repair) I recovered almost 100%, after step 2 (A-base addition) about 70%, and after step 3 (adapter ligation) about 75%. However, I use 37 degree buffer EB and elute twice. (so basically I started with 100ng and ended up with a bit over 50ng going into the size selection step).
I've tried Ampure and the recovery was good but took a lot longer. A neighboring lab recently tested Ampure, Ampure XP, and Qiagen and the Ampure XP was the best in their hands. We'll switch to Ampure XP when we run out of the minelute columns.
Comment
-
-
1. It is recommended to use freshly prepared 80% EtOH.
2. 15 min incubation to bind DNA with multiple vortexing steps during this time period...~10sec per vortex should be fine...just mix things up.
3. It is okay to pipet the beads with the EtOH to mix them (I call this "triterating"), but I usually mix them using the magnet...back and forth. BUT, you can also just add the EtOH and do no mixing at all.
4. As it is recommended to elute 90uL of beads with no less than 30uL, I have sucessfully eluted 160uL of beads with 17uL, with minimal losses...just give it a little extra time.
5. I always spin down my tubes after any mixing/vortexing prior to placing tubes back on the magnet or leaving for further incubation...just a quick spin to get stuff off the tube walls...not compacting the beads.
6. There are better "cleaners/concentrators" than Qiagen...maybe the Zymo...as far as losses go. AMpure XP seems to be the best for yields, but does take much longer. For Qiagen-type column units I tend to bind the DNA twice, and elute twice...same PB/EB, just put it back into the column and spin again. Also, let the EB sit for at least 1min on the filter before spinning.
Comment
-
-
Just to add clarification, usually the loss is associated with the "dead volume" (i.e. the liquid between beads) and sometimes the wetting of the plastic surface. So the more beads you use, the greater the dead volume and the poorer your recovery.Originally posted by niceday View PostECO is that 2-3 minutes on a vortex?
I recently eluted some samples after ampure cleanup. Out of curiosity I re-eluted the beads for 3 hours and got 15% DNA back. I'll be speaking to some people to find out if this is the norm.
In my experience it also depends on how "flattened" the magnetized pellet is, which is why sometimes I use really strong rare-earth magnets for the post wash elution rather than anything on a stand.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
32 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
Comment